Research
Ianalumab reduces Sjögren disease activity
Nature ·
The Brief
- Headline reports that ianalumab reduces Sjögren disease activity.
- The item comes from a Nature subject feed dated 2026-11-10 and has no summary.
Why it matters
Sjögren disease is an autoimmune condition with limited targeted treatments, so a reported reduction in disease activity with ianalumab is relevant to rheumatology research. The source provides no further detail on methods or results.
Who’s affected
- rheumatologists and clinicians treating Sjögren disease
- patients with Sjögren disease
- #sjogren
- #ianalumab
- #autoimmune
- #rheumatology
- #disease activity